Actively Recruiting

Age: 18Years - 130Years
All Genders
NCT05557695

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

Led by AstraZeneca · Updated on 2026-04-23

350

Participants Needed

29

Research Sites

232 weeks

Total Duration

On this page

Sponsors

A

AstraZeneca

Lead Sponsor

U

UKCLL Forum

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a retrospective observational research study to describe the characteristics and real-world clinical outcomes of patients with chronic lymphocytic leukaemia receiving acalabrutinib in the United Kingdom (the EPIC study). Physicians treating chronic lymphocytic leukaemia patients with acalabrutinib, where the patients started treatment as part of the acalabrutinib Early Access Programme (EAP), will be invited to recruit patients. Clinical data will be extracted from the patients' clinical records in line with local laws. Data from this study will provide UK-specific real-world data on patients who were started on acalabrutinib as part of the UK acalabrutinib EAP.

CONDITIONS

Official Title

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

Who Can Participate

Age: 18Years - 130Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Treatment-na�efve patients with chronic lymphocytic leukaemia (CLL) who started acalabrutinib as part of the UK Early Access Programme
  • Received their first dose of acalabrutinib between April 1, 2020, and April 1, 2021
  • Patients aged 18 years or older
  • Patients later found to have small lymphocytic lymphoma (SLL) may also be included
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 29 locations

1

Research Site

Aylesbury, United Kingdom

Actively Recruiting

2

Research Site

Bath, United Kingdom

Actively Recruiting

3

Research Site

Birmingham, United Kingdom

Actively Recruiting

4

Research Site

Bournemouth, United Kingdom

Actively Recruiting

5

Research Site

Cardiff, United Kingdom

Actively Recruiting

6

Research Site

Cornwall, United Kingdom

Actively Recruiting

7

Research Site

Dartford, United Kingdom

Actively Recruiting

8

Research Site

Derby, United Kingdom

Actively Recruiting

9

Research Site

Doncaster, United Kingdom

Actively Recruiting

10

Research Site

Dorset, United Kingdom

Actively Recruiting

11

Research Site

Eastbourne, United Kingdom

Actively Recruiting

12

Research Site

Hull, United Kingdom

Actively Recruiting

13

Research Site

Leicester, United Kingdom

Actively Recruiting

14

Research Site

Lincoln, United Kingdom

Actively Recruiting

15

Research Site

Liverpool, United Kingdom

Actively Recruiting

16

Research Site

London, United Kingdom, SE1 9RT

Actively Recruiting

17

Research Site

London, United Kingdom, W12 OHS

Actively Recruiting

18

Research Site

Mid Yorkshire, United Kingdom

Actively Recruiting

19

Research Site

Middlesbrough, United Kingdom

Actively Recruiting

20

Research Site

Newcastle, United Kingdom

Actively Recruiting

21

Research Site

North Shields, United Kingdom

Actively Recruiting

22

Research Site

Norwich, United Kingdom

Actively Recruiting

23

Research Site

Nottingham, United Kingdom

Actively Recruiting

24

Research Site

Oxford, United Kingdom

Actively Recruiting

25

Research Site

Plymouth, United Kingdom

Actively Recruiting

26

Research Site

Southampton, United Kingdom

Actively Recruiting

27

Research Site

Stockton-on-Tees, United Kingdom

Actively Recruiting

28

Research Site

Stoke-on-Trent, United Kingdom

Actively Recruiting

29

Research Site

Wigan, United Kingdom

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here